08.27.26 -- In Bioprocessing, Trusted Data Is A Process Variable

Alarm monitoring can be more than compliance. Learn how unified data and real-time insights helped one pharma company unlock efficiency, predictive analytics, and a path to digital transformation.

See how downstream processing affects CD73 expression and function on MSC-EVs through orthogonal analytical methods that connect vesicle content to biological activity and therapeutic potential.

By collecting, harmonizing, and contextualizing data to support predictive insights and real-time monitoring, manufacturers can improve operational responsiveness and make more informed decisions.

Discover an innovative approach to drug conjugation that expands the range of molecules suitable for targeted therapies while preserving their biological activity and enabling controlled drug release.

Disconnected systems can slow development by making data harder to coordinate. Uncover how workflow orchestration and structured design can help labs reduce friction and improve efficiency.

Disconnected systems and siloed data block analytics in life sciences manufacturing. Bridge the infrastructure gap and build a connected foundation for scalable intelligence.

Examine how emerging pharma manufacturers are compressing recipe digitalization from months to weeks, reducing human error, and accelerating time-to-market using automated template conversion.

Digital validation tools help teams cut cycle times, reduce labor hours, and strengthen compliance. Read more about measurable efficiency gains and steps for adopting a digital validation approach.

Disconnected systems slow investigations and delay batch release. Delve into a digitally connected execution ecosystem that provides real-time context for alerts, enabling proactive control.

Explore how an approach with modular N-1 perfusion strategies shortens seed train timelines and reduces facility strain — enabling upstream processes that scale efficiently and reliably.

Find out how transitioning to cloud-native architectures drives business agility in biopharma, reducing infrastructure costs, minimizing downtime, and accelerating time to market for novel therapies.

Eliminate particulate contamination and product degradation in downstream bioprocessing. Gain insight into how frictionless, levitating impeller technology ensures low-shear mixing and high yields.

As drug modalities grow more complex, speed depends on smarter decisions. Take a look at how bioprocessing equipment choices play a larger role in enabling momentum than many teams realize.

Unplanned downtime often starts with a missing spare part. Observe how lean, data‑driven inventory strategies can reduce risk, support compliance, and keep bioprocessing operations running smoothly.

Learn essential conceptual design principles for transforming alternative spaces into efficient, regulatory-aligned cleanroom environments for your critical processes.

Optimize particle removal with filtration strategies tailored to process conditions, boosting efficiency, protecting product quality, and reducing contamination risk in small molecule manufacturing.

Read how the incorporation of transfer sets designed to support CGTs will aid in the implementation of controllable, consistent, and safe cGMP amenable manufacturing procedures.

Airborne microbial contamination is a serious concern for companies producing medicines and biotech products, and it must be addressed to ensure that products and people are kept safe.

Single-use technologies are reshaping biomanufacturing workflows. Discover the key stages of implementation and how strategic choices drive success across the entire production process.

Annex 1’s updated CCS framework calls for a holistic contamination strategy. Explore how manufacturers can apply it to non-sterile sites and legacy facilities using tailored risk-based approaches.